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Abstract Primary central nervous system lymphoma
(PCNSL) is an extranodal non-Hodgkin lymphoma involving
brain, intraocular structures and spinal cord, without evidence
of systemic disease. The majority of PCNSLs are diffuse large
B-cell type. We encountered a rare case of primary dural
marginal zone lymphoma of mucosa-associated lymphoid
tissue (MALT) with extension into the brain in a 59-year-old
man. A magnetic resonance imaging scan showed a 22-mm
tumor located in the left posterior temporal lobe extending from
the dura. Histopathology revealed a lymphoplasmacytic infil-
tration of the dura and the brain parenchyma in a perivascular
pattern. Immunohistochemical and in situ hybridization studies
showed a B-cell phenotype with kappa light chain restriction.
Fluorescent in situ hybridization study showed a t(14;18)(q32;
q21) with immunoglobulin heavy-chain/MALT1 fusion. The
molecular study for immunoglobulin heavy-chain gene rear-
rangement by polymerase chain reaction showed a clonal gene
rearrangement.
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Introduction
Themajorityofthecentralnervoussystem(CNS)lymphomas
are due to the spread of a systemic lymphoma to the CNS
[1, 2]. Primary central nervous system lymphoma (PCNSL)
is an extranodal non-Hodgkin lymphoma (NHL) that in-
volves the brain, leptomeninges, intraocular structures, or
spinal cord in the absence of systemic disease. It occurs in
both immunocompromised and immunocompetent patients
and accounts for 2.7% of all malignant diseases of the
central nervous system [3]. The incidence of PCNSL has
increased during the last three decades, and it occurs at a
younger age in the immunocompromised patients.
According to World Health Organization classification
[4], the majority of PCNSL are diffuse large B-cell
lymphoma. T-cell (T-PCNSL), low grade B-cell lymphomas,
andanaplasticlargecelllymphomaoftheCNSareextremely
rare [5, 6]. The PCNSL in human immunodeficiency virus
positive patients is almost always associated with the
Epstein–Barr virus (EBV), while the association of EBV
in immunocompetent patients is rare [7].
The majority of PCNSL presents as a space-occupying
lesion within the brain parenchyma and periventricular
regions. Primary dural CNS lymphomas are extremely rare.
The majority of them are low grade NHL, with marginal
zone B-cell lymphoma being the most common. There are
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e-mail: jchan@unmc.eduonly a handful of case reports and a small case series which
describe the dural involvement [8–10]. In the present study,
we describe the clinical, histopathological, immunohisto-
chemical, cytogenetic, and molecular findings of a case of
primary extranodal marginal zone lymphoma involving the
dura with extension to the brain parenchyma in an immuno-
competent patient. This is the first report of a primary dural
marginal zone lymphoma of mucosa-associated lymphoid
tissue(MALT)typethathasshownamolecularrearrangement
of t(14;18)(q32;q21) involving the MALT1gene.
Material and methods
All available routine hematoxylin and eosin, immunohisto-
chemical, and in situ hybridization slides of formalin-fixed
paraffin-embedded tissue from a diagnostic biopsy of the
patient were reviewed. Working antibody source, clone, and
dilution are listed in Table 1. Staining was performed on an
automated immunostainer (Ventana Medical Systems, Tuscon,
AZ and Dako, Carpentaria, CA, USA). For in situ hybridiza-
tion (ISH), slides were deparaffinized and antigen retrieval
was performed by a Ventana’s proprietary protease-1 treat-
ment. Subsequently, the slides were incubated with undiluted
Kappa, Lambda, and EBV probe solutions from Ventana.
Fluorescent in situ hybridization
Fluorescence in situ hybridization (FISH) was performed
on 4–5-μm unstained paraffin-embedded tissue sections
using the LSI immunoglobulin heavy-chain (IgH)/MALT1
dual-fusion translocation probe and the LSI BCL6 (3q27)
dual-color break-apart probe obtained from Vysis/Abbott,
Inc. (Downer’s Grove, IL, USA). Prior to hybridization, the
slides were pretreated by utilizing the VP 2000 automated
slide processor (Vysis/Abbott, Inc.) following a modified
version of the manufacturer’s recommended protocol.
Codenaturation of the DNA probe and the tissue DNA
was performed on a HYBrite
™ instrument (Vysis/Abbott,
Inc., IL, USA) at 80°C for 5 min, followed by an
overnight hybridization at 37°C, postwashed in 2× SSC/
0.3% NP-40 at 73°C for 2 min, and counterstained with
4′,6-diamidino-2-phenylindole II.
Molecular diagnostics
Immunoglobulin heavy-chain gene rearrangements were
analyzed by using the InVivoScribe IgH framework III/
heavy-chain joining (JH) assay, according to the manufac-
turer’s protocol (InVivoScribe Technologies, San Diego,
CA, USA). Framework II/JH segments were amplified
using the forward (5′ TGG RTC CGM CAG SCY YCN GG
3′) and reverse (5′ 6-FAM ACC TGA GGA GAC GGT GAC
C3′) primers as previously described [11]. Polymerase chain
reaction (PCR) products were analyzed using a capillary
electrophoresis as described previously [12].
Case report
The patient was a 59-year-old gentleman, who presented
with speech difficulties, right-sided numbness, and episodes of
unusual smell for 8 months. He did not have a history of
headache, seizures, and inflammatory conditions. A magnetic
resonance imaging scan showed a heterogeneously enhancing
22-mmtumorlocatedintheleftposteriortemporallobeabutting
the dura. Subsequently, he underwent left temporal craniotomy
and microsurgical resection of the tumor. The patient underwent
computed tomography scans of the chest, abdomen, and pelvis
(staging), with normal findings. Bone marrow aspiration and
biopsy examinations did not reveal any evidence of lymphoma.
A work-up for monoclonal gammopathy including serum
protein electrophoresis and serum level of immunoglobulin A,
G, and M showed normal results.
Results
The histopathology of the tumor showed a prominent
lymphoplasmacytic infiltration in the brain parenchyma
and the overlying fibrous (dura) tissue. The tumor showed
a characteristic, angiocentric pattern, forming cuffs of tumor
cells around the cerebral blood vessels (Virchow–Robin
space;Fig.1A,B). Most of the lymphocytes were small with
condensed chromatin in a round to slightly irregular
nucleus and a scant to moderate amount of pale cytoplasm.
A prominent plasma cell population was present. Reactive
lymphoid follicles were not identified.
Immunohistochemical studies showed that the tumor
cells were positive for B-cells markers (cluster of differen-
Table 1 Panel of antibodies
Antibody to Clone Company Dilution
CD20 L26 Dako
a 1:500
CD79a JCB117 Dako 1:80
CD3 F7.2.38 Dako Neat
CD5 SP19 Ventana
b Neat
Cyclin D1 SP4 Ventana 1:100
CD21 1F8 Dako 1:80
Ig G A57H Dako 1:200
Ig M R1/69 Dako 1:200
CD10 56C6 Ventana Neat
aDako, Carpenteria, CA, USA
bVentana, Tucson, AZ, USA
132 J Hematopathol (2008) 1:131–137tiation (CD) 20, CD79a; Fig. 1C,D). The neoplastic plasma
cells were monoclonal for Ig G and kappa light chain
(Fig. 1E), and negative for lambda light chain (Fig. 1F).
The tumor cells were immunonegative for CD3, CD5,
cyclin D1, CD21, CD23, CD10, and Ig M. EBV testing by
ISH (EBV-encoded small RNA) was negative. The FISH
study for MALT1 translocations showed a rearrangement of
the MALT1 region at 18q21 in 30% of the interphase cells.
Subsequent studies showed fusion of IgH/MALT1 in 74%
of the cells (Fig. 1G). Additional studies for trisomy 3 and
7 were negative. The molecular study for IgH rearrange-
ment by PCR showed a single peak indicating clonal
immunoglobulin heavy-chain gene rearrangement using the
primers for heavy-chain variable (VH; framework II) and
JH regions (Fig. 2). The tumor was negative for clonal IgH
gene by PCR using the primers to VH framework III and
JH regions. The staging evaluation was negative for
systemic involvement by lymphoma.
Discussion
Isaacson and Wright were the first to describe the marginal
zone B-cell lymphoma (MZL) in mucosa-associated lym-
phoid tissue of the gastrointestinal tract in 1983 [13].
Depending on the site of involvement, the MZL is
classified into three subtypes: (1) splenic MZL, (2) nodal
MZL, and (3) extranodal MZL of the mucosa-associated
lymphoid tissues type [14, 15].
Among the MALT lymphomas, the gastrointestinal tract
and lungs are the most common sites [16]. It is also
recognized in salivary glands, skin, thyroid, lung, ocular
adnexa, liver, CNS, and breast [17]. MALT lymphoma of
the CNS is extremely rare. Dural MALT lymphoma is the
most common site of involvement in the CNS with a rare
occurrence in the lateral ventricle [18, 19].
To date, 39 cases of primary dural MALT lymphomas
have been reported in the literature (Table 2). They usually
Fig. 1 Morphologic, immuno-
histochemical, Ig light chain
expression and FISH assay of
the PCNS MALT lymphoma.
A and B Histopathology of the
lymphoma showing a prominent
lymphoplasmacytic infiltration
with a characteristic perivascular
pattern (hematoxylin–eosin,
original magnification, ×100
and ×400). C and D Many of the
lymphoma cells were positive
for CD 20 and CD 79a
(immunohistochemistry ×100).
E In situ hybridization showing
the tumor cells are kappa light
chain restricted (×100). F In situ
hybridization showing the tumor
cells are lambda light chain
negative (×100). G FISH analy-
sis showing the interphase cells
with IGH/MALT1 rearrange-
ment indicated by two fusion
signals (juxtaposed green and
red signal). The normal IgH and
MALT1 loci are represented by
the single red and single green
signals respectively (×100)
J Hematopathol (2008) 1:131–137 133occur in the middle-aged to elderly women and present
with headache, seizures, and visual disturbance [18].
Although CNS is devoid of mucosal tissue, it has been
hypothesized that the meningothelial cells serve as a
substitute for the mucosal surface in MALT lymphoma of
the CNS [20, 21].
MALT lymphomas typically present as a local mass
without bone marrow and lymph node involvement in
Fig. 2 Immunoglobulin heavy-chain gene rearrangement study—PCR product analyzed by capillary electrophoresis showing a clonal
rearrangement. X axis length of amplicon, Y axis intensity of signal
Table 2 Clinicopathological features of the reported cases of primary central nervous system lymphoma of mucosa-associated lymphoid tissue type
Case Reference Location of dura Presenting
symptoms
Age
(years)
Sex Preexisting
condition
Treatment FISH
studies
IgH
studies
Follow up
(months)
Status
1 Kumar et al.
[21]
Cavernous sinus Numbness and
visual field defects
40 F None RT ND ND 63 CR1
2 Kumar et al.
[21]
Biparietal Seizures 62 F None Chemo ND Mono 22 CR1
3 Kumar et al.
[21]
Frontal Seizures; numbness 52 F None RT and
chemo
ND Mono 7 CR1
4 Kumar et al.
[21]
Tentorium Headache, visual
defect, numbness
43 F None RT ND Negative 9 CR1
5 Kumar et a1.
[21]
Falx cerebri Seizures 57 F None RT ND Mono 14 CR1
6 Kambham et al.
[26]
Tentorium Hearing loss,
weakness
39 F None Resection ND Mono 48 AWD
7 Kambham et al.
[26]
Frontoparietal Headache, visual
defect, numbness
62 F None Resection
and RT
ND Negative 6 AWD
8 Altundag et al.
[27]
Parietal Seizures 66 F None Resection ND ND 12 CR1
9 Itoh et al.
[20]
Cerebellopontine Tinnitus, headache 28 F Sjogren's
syndrome
Resection ND ND 24 CR1
10 Sanjeevi et al.
[28]
Cavernous sinus Headache, visual
defect
46 F Grave's
disease
Resection
and RT
ND ND 15 CR1
11 Goetz et al.
[29]
Frontoparietal Hemiparesis 64 F None Resection
and RT
ND ND 3 CR1
12 Bodi et al. [30] Frontal Seizures, dizziness 56 F None Resection ND ND 18 CR1
13 Lehman et al.
[31]
Falx cerebri Seizures, speech
defect
63 F None RT ND ND 8 AWD
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Case Reference Location of dura Presenting
symptoms
Age
(years)
Sex Preexisting
condition
Treatment FISH
studies
IgH
studies
Follow up
(months)
Status
14 Benouaich et al.
[32]
Frontoparietal Headache 38 F None RT and
chemo
ND ND 24 CR1
15 Benouaich et al.
[32]
Temporal,
parieto-occipital
Headache 45 F None RT and
chemo
ND ND 12 CR1
16 Kelly et al.
[18]
Choroid plexus Headache, seizures 53 M None Resection
and RT
Negative ND 12 CR1
17 Tu et al. [25] Falx cerebri NA 56 F None Not
available
Tri 3 Negative NA NA
18 Tu et al. [25] Frontal dura Seizures 49 M None Chemo Tri 3 Negative 90 CR1
19 Tu et al. [25] Frontal dura Seizures 66 M None RT Tri 3 Negative 13 CR1
20 Tu et al. [25] Posterior fossa NA 55 F None NA ND Negative NA NA
21 Tu et al. [25] Middle cranial
fossa
NA 45 F None NA ND Negative NA NA
22 Tu et al [25] NA NA 68 F None NA Tri 3 Negative NA NA
23 Tu et al. [25] Subdural NA 29 F None RT Negative Negative 36 CR1
24 Tu et al. [25] Frontotemporal Headache,
drowsiness
61 F None NA Negative Negative 21 CR1
25 Tu et al. [25] Occipital Ataxia 62 F None RT Tri 3, 7,
12, 18
Negative 25 CR1
26 Tu et al. [25] Parietal Facial drop,
numbness,
dysarthria
47 M None NA ND ND NA NA
27 Tu et al. [25] Frontoparietal Right arm pain 57 F None RT and
chemo
Negative Negative 65 CR1
28 Tu et al. [25] Tentorium Visual deficits 70 F None RT Negative Negative 45 CR1
29 Tu et al. [25] Falx Gait disturbance,
visual deficits
59 F None RT Negative Negative 32 CR1
30 Tu et al. [25] Suprasellar, sella Headache, visual
deficits
53 F None RT Negative Negative 11 CR1
31 Tu et al. [25] Falx tentorium Headache, ear pain 48 F None RT and
chemo
Tri 3, 7,
12, 18
Negative 20 CR1
32 Iwamoto et al.
[33]
Temporoparietal Headache, facial
weakness
64 F None Resection
and
chemo
ND ND 78 CR1
33 Iwamoto et al.
[33]
Frontotemporal Seizures, visual
defects
33 F None RT and
chemo
ND ND 84 CR1
34 Iwamoto et al.
[33]
Tentorium,
temporal
Headache,
dizziness,
numbness
35 M None RT and
chemo
ND ND 53 CR1
35 Iwamoto et al.
[33]
Tentorium Seizures 47 M None RT ND ND 27 CR1
36 Iwamoto et al.
[33]
Frontal, sphenoidal Visual deficits,
paresthesias
39 F None RT ND ND 6 CR1
37 Iwamoto et al.
[33]
Parietal Seizures 49 F None RT ND ND 7 CR1
38 Iwamoto et al.
[33]
Frontal Headache 51 F None RT ND ND 8 CR1
39 Iwamoto et al.
[33]
Frontal Headache, visual
deficits
50 F None RT ND ND 5 CR1
40 Bhagavathi et al.
[present report]
Temporal Altered speech,
numbness
59 M None RT t(14;18)
(q32;
q21)
Mono 1 AWD
M Male, F female RT radiotherapy, chemo chemotherapy, ND not done, CR complete remission, AWD alive with disease, NA not available, FISH
fluorescent in situ hybridization, IgH immunoglobulin heavy-chain gene rearrangement, mono monoclonal
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marginal zone B-cells and show a spectrum of cellular
constituents, from small lymphocytes to monocytoid B-cells
to plasma cells. The lymphocytes express B-cell markers
(CD19, CD20, and CD79a) and are negative for CD3, CD5,
CD10, CD23, and cyclin D1.
In the present case, the morphological, immunohisto-
chemical, and in situ hybridization studies showed that the
lymphoma is a low grade MZL, with prominent plasma cell
differentiation that is Ig G and kappa light chain restricted.
The tumor infiltrated into the underlying brain parenchyma
in a perivascular pattern. Small lymphocytic lymphoma/
chronic lymphocytic leukemia and mantle-cell lymphomas
were excluded by the negative immunostaining for CD5,
CD23, and cyclin D1. Follicular lymphoma and lympho-
plasmacytic lymphoma were excluded by the morphology,
negative CD10, normal serum Ig M, and negative bone
marrow examination.
Infectious or inflammatory conditions were ruled out by
the demonstration of a dominant clonal population. In situ
hybridization showed that the plasma cells are Kappa light
chain restricted, while molecular study for IgH gene
rearrangement showed a clonal immunoglobulin heavy-
chain gene rearrangement.
MALT lymphoma, notably in the lung and gastrointes-
tinal tract, often has a characteristic t(11;18)(q21;q21)
translocation. In this translocation, the 3′ end of MALT1
was fused to the 5′ portion of API2, an inhibitor of
apoptosis located at 11q21 leading to production of API2-
MALT1 fusion transcript [22]. The frequency of this
translocation varies depending on the site of origin of the
tumor and it was absent or present at very low frequencies
in thyroid, skin, liver, and other rare sites [23].
Streubel et al. [24] have identified a second chromo-
somal aberration involving the MALT1 gene and IgH on
14q32 rather than the API2. Their study showed that 18%
(12 out of 66) of the MALT lymphomas were positive for
t(14;18)(q32;q21). Interestingly, the anatomical distribution
of MALT lymphoma with t(14;18)(q32;q21) was different
from that with t(11;18)(q21;q21). The t(14;18) was positive
in MALT lymphoma involving ocular adnexa, skin, and
the salivary glands, and negative in pulmonary and
gastrointestinal MALT lymphoma. MALT lymphomas with
different chromosomal abnormalities involving different
anatomical sites may indicate different pathogenetic path-
ways, e.g., the gastric MALT lymphoma is associated with
H pylori, whereas those of ocular adnexa, skin, and salivary
glands may be associated with other infectious agents or
autoimmune diseases.
In the present case, FISH study showed a positive
rearrangement of the MALT1 locus. Subsequent studies
showed IgH/MALT1 fusion. To our knowledge, this is the
first case of primary dural lymphoma of MALT type with a
translocation involving IgH and MALT1 genes. The largest
series of dural MALT lymphoma reported in the literature
was by Tu et al. [25]. They were able to perform FISH
study in 12 of the 15 cases. None of their cases showed
t(14;18) or t(11;18) translocations. However, 50% of their
cases showed trisomy 3 (six out of 12 cases) while our case
was negative for this abnormality. Similarly, Kelly et al.
[18] have also performed FISH study in their case report
and the result was negative for t(11;18) and t(14;18).
Additional cases of dural MALT lymphoma need to be
studied by FISH to determine the precise frequency of
MALT1 rearrangement. Our case suggests that MALT1
translocation play a pathogenetic role in some PCNS MALT
lymphoma similar to the other extranodal lymphoma.
In conclusion, we report a rare case of primary dural
MALT lymphoma with prominent plasmacytic differentia-
tion and the diagnosis was confirmed by a monoclonal IgH
gene rearrangement and a positive MALT1 rearrangement
involving IgH and MALT1 on chromosome 14 and 18,
respectively.
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